Detalhe da pesquisa
1.
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 116(1): 44-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19853287
2.
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
Am J Obstet Gynecol
; 199(5): 539.e1-6, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18565487
3.
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
J Clin Oncol
; 20(7): 1832-7, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11919241
4.
Gemcitabine in cervical cancer.
Gynecol Oncol
; 90(2 Pt 2): S8-15, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12928000
5.
Treatment of ovarian cancer: new strategies.
Gynecol Oncol
; 90(2 Pt 2): S24-32, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12928003
6.
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.
Gynecol Oncol
; 89(1): 148-54, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12694669
7.
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 92(3): 744-51, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14984936